The US Federal Trade Commission approved the purchase of the Irish pharmaceutical company Shire by Japanese Takeda Pharmaceutical, the largest pharmaceutical company in Asia, for 46 billion pounds sterling. The message of Takeda said that the deal would lead the Japanese company into the top 10 pharmaceutical companies in the world in terms of revenue. Takeda expects that the deal, which is the largest in the history of deals of the Japanese companies with the purchase of foreign assets, will be closed in the first half of 2019. The deal has yet to be agreed in a number of other countries, including the EU, Japan and China.
Miniso Group plans to raise its IPO to $562.4 Million02.10.2020
Goldman Sachs to purchase General Motors’ credit card business worth $2.5 billion29.09.2020
Toyota says its annual global sales could reach $5.5 Million in five years23.09.2020
KKR & Co to invest $755 Million in Reliance Industries' retail arm